Trial record 1 of 1 for:    B1931008
Previous Study | Return to List | Next Study

A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy

This study has been terminated.
(The study was terminated prematurely on May 16, 2013, for futility. No new or unexpected safety issues were identified.)
UCB Pharma
Information provided by (Responsible Party):
Pfizer Identifier:
First received: October 27, 2010
Last updated: May 29, 2014
Last verified: May 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2014
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: May 29, 2014